CytoSorbents Corporation (NASDAQ: CTSO) stock closed at 1.21 per share at the end of the most recent trading day (a 1.68% change compared to the prior day closing price) with a volume of 49.25K shares and market capitalization of 53.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 156 people. CytoSorbents Corporation CEO is Phillip P. Chan.

The one-year performance of CytoSorbents Corporation stock is -13.14%, while year-to-date (YTD) performance is -21.94%. CTSO stock has a five-year performance of -88.41%. Its 52-week range is between 1.03 and 4.59, which gives CTSO stock a 52-week price range ratio of 5.06%

CytoSorbents Corporation currently has a PE ratio of -2.10, a price-to-book (PB) ratio of 2.21, a price-to-sale (PS) ratio of 3.84, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -57.92%, a ROC of -60.46% and a ROE of -83.58%. The company’s profit margin is -91.55%, its EBITDA margin is -105.90%, and its revenue ttm is $21.72 Million , which makes it $0.50 revenue per share.

Of the last four earnings reports from CytoSorbents Corporation, there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. CytoSorbents Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for CytoSorbents Corporation is Strong Buy (1), with a target price of $9, which is +643.80% compared to the current price. The earnings rating for CytoSorbents Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CytoSorbents Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CytoSorbents Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 24.68, ATR14 : 0.13, CCI20 : -71.42, Chaikin Money Flow : -0.14, MACD : -0.12, Money Flow Index : 20.36, ROC : -3.97, RSI : 40.01, STOCH (14,3) : 37.97, STOCH RSI : 0.16, UO : 53.17, Williams %R : -62.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CytoSorbents Corporation in the last 12-months were: Al W. Kraus (Option Excercise at a value of $31 800), Bator Michael (Buy at a value of $6 430), Kathleen P. Bloch (Buy at a value of $34 205), Phillip Chan (Option Excercise at a value of $87 840), Phillip P. Chan (Buy at a value of $60 950), Phillip P. Chan (Option Excercise at a value of $87 688), Vincent Capponi (Option Excercise at a value of $57 550)